Grifols | GRFS - رأس المال والاحتياطيات





رأس المال والاحتياطيات تغيير تاريخ
Alaunos Therapeutics USD 2.8M 858K 2025-09
Arca Biopharma USD 486.79M 143.15M 2025-09
aTyr Pharma USD 80.24M 5.58M 2025-09
Bio Path USD -7.16M 4.57M 2025-06
Brainstorm Cell Therapeutics USD -7.69M 1.64M 2025-09
Capricor Therapeutics USD 83.87M 21.11M 2025-09
Cara Therapeutics USD 32.93M 41M 2025-06
Esperion Therapeutics USD -451.36M 17.85M 2025-09
GlaxoSmithKline GBP 16.38B 229M 2025-12
Grifols EUR 6.08B 34.72M 2025-09
Immunic USD 10.5M 23.41M 2025-09
Infinity Pharmaceuticals USD -37.41M 9.08M 2023-06
Minerva Neurosciences USD -34.58M 2.47M 2025-09
Nektar Therapeutics USD 85.09M 109.3M 2025-09
Sangamo BioSciences USD 19.6M 14.7M 2025-06
TherapeuticsMD USD 27.67M 990K 2024-06